South Africa at a glance
- Population
- 64.7 million 2025
- Life expectancy at birth
- 66.3 years, 2024
- People aged 65 and over
- 6.9 % of people, 2025
- Health spending per person
- 537 US$ per person, 2023
- Doctors
- 0.79 per 1,000 people, 2022
Updated
Reviewed by Vidhi Upadhyay
South Africa Cell Therapy Manufacturing Market Industry Trends and Forecast to 2034: Segmented by (Product, Cell Type, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$95.0 Mn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $23.7 Mn | — | — |
| 2025 (base) | $27.9 Mn | +$4.2 Mn | — |
| 2026 (forecast) | $32.9 Mn | +$5.0 Mn | +17.9% |
| 2027 (forecast) | $38.8 Mn | +$5.9 Mn | +39% |
| 2028 (forecast) | $45.8 Mn | +$7.0 Mn | +63.9% |
| 2029 (forecast) | $54.0 Mn | +$8.2 Mn | +93.2% |
| 2030 (forecast) | $63.6 Mn | +$9.7 Mn | +127.8% |
| 2031 (forecast) | $75.0 Mn | +$11.4 Mn | +168.6% |
| 2032 (forecast) | $88.5 Mn | +$13.4 Mn | +216.7% |
| 2033 (forecast) | $104.3 Mn | +$15.8 Mn | +273.3% |
| 2034 (forecast) | $123.0 Mn | +$18.7 Mn | +340.2% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $27.9 Mn placeholder estimate |
|---|---|
| Forecast, 2034 | $123.0 Mn placeholder estimate |
| Growth (CAGR), 2025–2034 | 17.9% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Product, cell type and end user (see all) |
| Key players | Lonza Ltd, Thermo Fisher Scientific Inc., Cytiva (Danaher), Miltenyi Biotec, Charles River Laboratories and 1 more (see all) |
| Regulator in South Africa | SAHPRASource: South African Health Products Regulatory Authority. Checked 14 Nov 2026. |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Cell therapy manufacturing covers the equipment, materials and services used to grow, change and package living cells for treatment.
Key segments of the cell Therapy Manufacturing market include product (Consumables, Equipment and Services) and cell type (T Cells, Stem Cells and NK Cells).
Approvals of the first curative gene and cell therapies, strong investment in biotech, better manufacturing and growing evidence in rare and blood diseases are driving the cell Therapy Manufacturing market.
Allogeneic (off-the-shelf) products, in-vivo delivery and use in common diseases open large growth for the cell Therapy Manufacturing market.
Very high prices, complex manufacturing, limited treatment centres and uncertain long-term safety hold back the cell Therapy Manufacturing market. Payers are still working out how to pay for one-time cures.
The cell Therapy Manufacturing market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
The South African Health Products Regulatory Authority (SAHPRA) registers medicines.[1] Most people use public health services and a minority belong to private medical schemes; the National Health Insurance Act, signed in May 2024, plans to fund care for everyone.[2]
[1] South African Health Products Regulatory Authority. Checked 14 Nov 2026.
[2] National Department of Health. Checked 14 Nov 2026.
Regulators such as the US FDA, the European Medicines Agency and national drug authorities set approval, pricing and safety rules for cell Therapy Manufacturing. Reimbursement decisions by public payers and insurers shape how fast new therapies reach patients in South Africa.
What doctors and scientists are doing in Cell Therapy Manufacturing right now, from free public sources.
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 19 Nov 2026.
[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 19 Nov 2026.
[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 19 Nov 2026.
South Africa · 3 shared keywords
South Africa · 2 shared keywords
South Africa · 2 shared keywords
South Africa · 1 shared keyword
South Africa · 1 shared keyword
South Africa · 1 shared keyword
Healthcare Services · South Africa
Healthcare Services · South Africa
Healthcare Services · South Africa
Healthcare Services · South Africa
Healthcare Services · South Africa
Healthcare Services · South Africa